Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 121 AL 135

Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis

Wu Y, Zhu L, Chen J, Liu J, Yin K, Yang X.

J Neurol. 2026 Oct 21;273(11):675. doi: 10.1007/s00415-026-14224-y.

Continuous amyloid staging complements global amyloid burden in early Alzheimer's disease

Liu H, Tong M, Fang S, Mormino EC, Sperling RA, Aisen P, Buckley RF, Crane PK, Hohman TJ, Saykin AJ, Yan J; Alzheimer’s Disease Neuroimaging Initiative.

bioRxiv [Preprint]. 2026 Oct 11:2026.10.03.756367. doi: 10.64898/2026.10.03.756367.

Plasma eMTBR-tau as a robust biomarker for Alzheimer's disease tangle pathology up to 10 years before death

Shi R, Zeng X, Farinas MF, Nafash MN, Smirnov DS, Kamboh MI, Snitz BE, Kofler JK, Cohen AD, Pascoal TA, Ikonomovic MD, Zetterberg H, Lopez OL, Karikari TK.

medRxiv [Preprint]. 2026 Oct 5:2026.09.29.26363951. doi: 10.64898/2026.09.29.26363951.

Real-world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China

Tang L, Chen X, Zhang L, Fan L, Chen N, Li C, Cai Z, Chen G, Chen H, Ye M, Zheng H, Li Q, Ke Z, Hu Z, Cao M, Yang D, Xu S, Xie C, Li X, Xu X, Yu M, Lian X, Hu H, Li H, Cai X, Chen H, Xu W, Cui G, Zhao Y, Dong J, Zhang L, Zhu X, Zhao H, Xu Y.

Alzheimers Dement. 2026 Oct;22(10):e71936. doi: 10.1002/alz.71936.

Pathway-specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease

Valentim C, Denecke J, Frerich S, Betthauser TJ, Li Y, Ahmadi R, Franzmeier N; Alzheimer's Disease Neuroimaging Initiative (ADNI); Malik R, Ewers M.

Alzheimers Dement. 2026 Oct;22(10):e71939. doi: 10.1002/alz.71939.

Simpson's Paradox, Amyloid Paradox, and Racial Differences

Xiong C, Luo J, Lu R, Hartz S, Kukull W, Schindler SE, Balls-Berry JE, Hassenstab J, Wolk DA, Gleason CE, Johnson SC, Sperling R, Johnson K, Roberson ED, Moulder KL, Gremminger E, Agboola F, Grant EA, Hornbeck R, Massoumzadeh P, Keefe S, Dierker D, Flores S, Holtzman DM, Benzinger T, Morris JC.

JAMA Netw Open. 2026 Oct 1;9(10):e2640868. doi: 10.1001/jamanetworkopen.2026.40868.

Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort

Beament M, Wiltshire K, Belder CRS, Abel E, Hart M, Heslegrave AJ, Lunn MP, Rosa-Grilo M, Swann O, Schott JM, Zetterberg H, Fox NC, Keshavan A.

Alzheimers Res Ther. 2026 Oct 27;18(1):238. doi: 10.1186/s13195-026-02180-8.

A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease

Kurz C, Leonhardt S, Hufnagel A, Wizemann S, Deutelmoser H, Menzel P, Perneczky R.

Alzheimers Res Ther. 2026 Oct 24;18(1):240. doi: 10.1186/s13195-026-02238-7.

Spatial navigation and the basal forebrain in Alzheimer's disease and other neurodegenerative diseases

Laczó M, Lerch O, Nedelska Z, Laczó J.

Trends Neurosci. 2026 Oct;49(10):886-902. doi: 10.1016/j.tins.2026.08.005. Epub 2026 Sep 5.

HMGB1 signalling in Alzheimer's disease: pathogenic roles and therapeutic prospects

Tyagi P, Kumari S, Sharma P, Dhapola R, Paidlewar M, Medhi B, HariKrishnaReddy D.

Int Immunopharmacol. 2026 Oct 15;187:117204. doi: 10.1016/j.intimp.2026.117204. Epub 2026 Aug 6.

High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF

Hosseini MS, Saheli M, RajiZadeh MA, Nematollahi-Mahani SN, Joushi S, Gaeini A, Khoramipour K, Sheibani V.

Biochem Biophys Res Commun. 2026 Oct 8;834:154463. doi: 10.1016/j.bbrc.2026.154463. Epub 2026 Aug 19.

Autophagy as a mechanistic link between physical exercise and Alzheimer's disease

Yu Z, Wang Y, Yang Y.

Neuroscience. 2026 Oct 15;614:307-317. doi: 10.1016/j.neuroscience.2026.08.026. Epub 2026 Aug 18.

The emerging role of NADPH oxidases (NOX) in Alzheimer's disease pathogenesis

Yadav A, Verma H, Kumari S, Gangwar P, Rao R, Yadav B, Kaur S, Dhiman M, Mantha AK.

Neuroscience. 2026 Oct 15;614:333-354. doi: 10.1016/j.neuroscience.2026.08.004. Epub 2026 Aug 6.

Challenges in Studying Synapses in Alzheimer's Disease

Südhof TC.

Ann Neurol. 2026 Oct;100(4):683-694. doi: 10.1002/ana.78331. Epub 2026 Aug 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias